Average of confirmed sales; the main valuation baseline.
Lowest active listing; an asking price, not a completed sale.
Reference-price movement; low volume can make it unstable.
More sales reduce the impact of individual transactions.
Sales answer “what is it worth”; listings answer “what does an available copy cost”.
SALES / VALUECompleted eBay sales; useful support, especially for the global market.
Transaction-based price; use it as the valuation baseline.
Transaction-based price; use it as the valuation baseline.
Seller asking prices. They show availability but do not prove demand.
| DATE | SOURCE | Price | Change |
|---|---|---|---|
| 2026-11-06 | List | €20.00 | -33.3% |
| 2026-11-06 | Sold | €17.59 | -3.4% |
| 2026-11-06 | TCG | $39.94 | — |
| 2026-11-05 | Sold | €18.20 | +51.8% |
| 2026-11-05 | TCG | $39.94 | +0.1% |
| 2026-11-05 | EB | $29.99 | -28.3% |
| 2026-11-04 | Sold | €11.99 | -1.6% |
| 2026-11-04 | TCG | $39.91 | -0.3% |
| 2026-11-04 | EB | $41.80 | +54.8% |
| 2026-11-03 | Sold | €12.18 | — |
| 2026-11-03 | TCG | $40.04 | +0.2% |
| 2026-11-02 | Sold | €12.18 | -11.9% |
| 2026-11-02 | TCG | $39.97 | — |
| 2026-11-01 | Sold | €13.82 | -2.8% |
SV02: Paldea Evolved / #201/193/Holofoil
France: lowest · United Kingdom: above average · EU average €26.96Choose a region above to inspect its prices and history.
DETAILED PRICES · Price History
| Condition/Grade | Price | LOW | HIGH | 7D CHG | Volume | Spark |
|---|---|---|---|---|---|---|
NMRAW | $35.90 | $29.99 | $29.99 | +23.7% | >5 | |
LPRAW | $38.64 | $38.64 | $38.64 | +23.7% | >5 | |
AggregatedRAW | €17.59 | €8.00 | €35.33 | +23.7% | >5 | |
MPRAW | $37.19 | $37.19 | $37.19 | +23.7% | >5 | |
HEAVILY PLAYEDRAW | $30.86 | $30.86 | $30.86 | +23.7% | >5 | |
DMGRAW | $9.99 | $9.99 | $9.99 | +23.7% | >5 | |
MINTRAW | $50.00 | $50.00 | $50.00 | +23.7% | >5 |
Explore Fuecoco #201/193, Holofoil from SV02: Paldea Evolved, with 2085 price records for the US market. Prices above are labeled by source, currency and condition. Asking prices and recorded sales are different measures, not interchangeable valuations.